270 related articles for article (PubMed ID: 37406506)
21. Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo.
Cui L; Hunter MR; Sonzini S; Pereira S; Romanelli SM; Liu K; Li W; Liang L; Yang B; Mahmoudi N; Desai AS
Small; 2022 Mar; 18(9):e2105832. PubMed ID: 34914866
[TBL] [Abstract][Full Text] [Related]
22. Payload distribution and capacity of mRNA lipid nanoparticles.
Li S; Hu Y; Li A; Lin J; Hsieh K; Schneiderman Z; Zhang P; Zhu Y; Qiu C; Kokkoli E; Wang TH; Mao HQ
Nat Commun; 2022 Sep; 13(1):5561. PubMed ID: 36151112
[TBL] [Abstract][Full Text] [Related]
23. Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery.
Tilstra G; Couture-Senécal J; Lau YMA; Manning AM; Wong DSM; Janaeska WW; Wuraola TA; Pang J; Khan OF
J Am Chem Soc; 2023 Feb; 145(4):2294-2304. PubMed ID: 36652629
[TBL] [Abstract][Full Text] [Related]
24. Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects.
Chen J; Xu Y; Zhou M; Xu S; Varley AJ; Golubovic A; Lu RXZ; Wang KC; Yeganeh M; Vosoughi D; Li B
Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2309472120. PubMed ID: 38060560
[TBL] [Abstract][Full Text] [Related]
25. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery.
Patel SK; Billingsley MM; Mukalel AJ; Thatte AS; Hamilton AG; Gong N; El-Mayta R; Safford HC; Merolle M; Mitchell MJ
Theranostics; 2024; 14(1):1-16. PubMed ID: 38164140
[TBL] [Abstract][Full Text] [Related]
26. High-Throughput
Hamilton AG; Swingle KL; Thatte AS; Mukalel AJ; Safford HC; Billingsley MM; El-Mayta RD; Han X; Nachod BE; Joseph RA; Metzloff AE; Mitchell MJ
ACS Nano; 2024 Jun; 18(25):16151-16165. PubMed ID: 38861479
[TBL] [Abstract][Full Text] [Related]
27. A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery.
Naidu GS; Yong SB; Ramishetti S; Rampado R; Sharma P; Ezra A; Goldsmith M; Hazan-Halevy I; Chatterjee S; Aitha A; Peer D
Adv Sci (Weinh); 2023 Jul; 10(19):e2301929. PubMed ID: 37092557
[TBL] [Abstract][Full Text] [Related]
28. Leveraging Biological Buffers for Efficient Messenger RNA Delivery via Lipid Nanoparticles.
Henderson MI; Eygeris Y; Jozic A; Herrera M; Sahay G
Mol Pharm; 2022 Nov; 19(11):4275-4285. PubMed ID: 36129254
[TBL] [Abstract][Full Text] [Related]
29. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
[TBL] [Abstract][Full Text] [Related]
30. Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles.
Tesei G; Hsiao YW; Dabkowska A; Grönberg G; Yanez Arteta M; Ulkoski D; Bray DJ; Trulsson M; Ulander J; Lund M; Lindfors L
Proc Natl Acad Sci U S A; 2024 Jan; 121(2):e2311700120. PubMed ID: 38175863
[TBL] [Abstract][Full Text] [Related]
31. A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes.
Ramishetti S; Hazan-Halevy I; Palakuri R; Chatterjee S; Naidu Gonna S; Dammes N; Freilich I; Kolik Shmuel L; Danino D; Peer D
Adv Mater; 2020 Mar; 32(12):e1906128. PubMed ID: 31999380
[TBL] [Abstract][Full Text] [Related]
32. In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA.
Medjmedj A; Ngalle-Loth A; Clemençon R; Hamacek J; Pichon C; Perche F
Nanomaterials (Basel); 2022 Jul; 12(14):. PubMed ID: 35889670
[TBL] [Abstract][Full Text] [Related]
33. Lipid nanoparticles containing labile PEG-lipids transfect primary human skin cells more efficiently in the presence of apoE.
Gregersen CH; Mearraoui R; Søgaard PP; Clergeaud G; Petersson K; Urquhart AJ; Simonsen JB
Eur J Pharm Biopharm; 2024 Apr; 197():114219. PubMed ID: 38368913
[TBL] [Abstract][Full Text] [Related]
34. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
[TBL] [Abstract][Full Text] [Related]
35. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.
Park S; Choi YK; Kim S; Lee J; Im W
J Chem Inf Model; 2021 Oct; 61(10):5192-5202. PubMed ID: 34546048
[TBL] [Abstract][Full Text] [Related]
36. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery.
Wang X; Liu S; Sun Y; Yu X; Lee SM; Cheng Q; Wei T; Gong J; Robinson J; Zhang D; Lian X; Basak P; Siegwart DJ
Nat Protoc; 2023 Jan; 18(1):265-291. PubMed ID: 36316378
[TBL] [Abstract][Full Text] [Related]
37. mRNA Vaccines Against SARS-CoV-2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids.
Chen K; Fan N; Huang H; Jiang X; Qin S; Xiao W; Zheng Q; Zhang Y; Duan X; Qin Z; Liu Y; Zeng J; Wei Y; Song X
Adv Funct Mater; 2022 Sep; 32(39):2204692. PubMed ID: 35942272
[TBL] [Abstract][Full Text] [Related]
38. Next-generation materials for RNA-lipid nanoparticles: lyophilization and targeted transfection.
Wang T; Sung TC; Yu T; Lin HY; Chen YH; Zhu ZW; Gong J; Pan J; Higuchi A
J Mater Chem B; 2023 Jun; 11(23):5083-5093. PubMed ID: 37221913
[TBL] [Abstract][Full Text] [Related]
39. Ionizable Lipids with Triazole Moiety from Click Reaction for LNP-Based mRNA Delivery.
Wang Y; Si X; Feng Y; Feng D; Xu X; Zhang Y
Molecules; 2023 May; 28(10):. PubMed ID: 37241787
[TBL] [Abstract][Full Text] [Related]
40. Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out.
De A; Ko YT
Expert Opin Drug Deliv; 2023 Feb; 20(2):175-187. PubMed ID: 36588456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
